Skip to content

Avedro CEO Reza Zadno Walks Us Through the Recent IPO, Reimbursement Wins, and Future Potential

Avedro’s

Episode 218

Avedro Inc. went public on February 14, raising $70 million with its share price at, coincidentally, $14. We talk with Reza Zadno, CEO and president, about the IPO, whose process, as you might imagine, was as difficult as it looks. We’ll also talk business. Avedro, of course, is a commercial enterprise now, reporting growing sales on its Corneal Cross-linking System that can be used to treat keratoconus, a non-inflammatory eye condition that weakens and misshapes the cornea. But what does the future hold for the start-up?

Do You Have

A STORY TO TELL?

If you’d like to be considered as a guest on a future episode of the OIS podcast, please complete the application today.

Meet Our New Host

EHSAN SADRI

Sadri_Ehsan

Joining the company in 2019, to create and manage a new line of podcasts, publications, and other editorial products.

Subscribe

ON iTUNES

Don't miss an episode. Join the conversation by visiting our podcast channel on iTunes today and subscribe. It's fast and free!

STAY UP TO DATE WITH OIS

Get the Latest News, Podcasts and Videos.

Scroll To Top